These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7083244)

  • 1. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I evaluation of semustine in a weekly schedule.
    Koller CA; Schwalm D; Liepman M; Natale RB; Wheeler RH
    Cancer Treat Rep; 1983 Jun; 67(6):579-81. PubMed ID: 6861164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of mitolactol in metastatic malignant melanoma.
    Simmonds MA; Lipton A; Harvey HA; Ellison N; White DS
    Cancer Treat Rep; 1985 Jan; 69(1):65-7. PubMed ID: 3967260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup.
    Carmo-Pereira J; Costa FO; Pimentel P; Henriques E
    Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU.
    Einhorn LH; Furnas B
    Cancer Treat Rep; 1977 Aug; 61(5):881-3. PubMed ID: 329981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
    Cohen MH; Schoenfeld D; Wolter J
    Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of mitolactol in advanced malignant melanoma.
    Murray N; Silver H; Shah A; Wilson K
    Cancer Treat Rep; 1985 Jun; 69(6):723-4. PubMed ID: 4016778
    [No Abstract]   [Full Text] [Related]  

  • 9. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R; Bernheim J; Cumps E; Buyse M; Kenis Y
    Cancer Treat Rep; 1981; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea.
    Bellet RE; Catalano RB; Mastrangelo MJ; Berd D
    Cancer Treat Rep; 1978 Dec; 62(12):2095-9. PubMed ID: 751717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A combination chemotherapy of ACNU and DTIC for advanced malignant melanoma].
    Domyo M; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Aiba K; Nagata T; Miyamoto H
    Gan To Kagaku Ryoho; 1982 May; 9(5):874-9. PubMed ID: 6964041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined chemotherapy of disseminated skin melanoma].
    Dement'eva NP; Voznyĭ EK; Koroleva LA
    Vopr Onkol; 1978; 24(11):48-53. PubMed ID: 741699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitolactol chemotherapy for malignant melanoma: a phase II study.
    Malden LT; Coates AS; Milton GW; McCarthy WH; Levi JA; Woods RL; Byrne MJ; Reynolds PM; Fox RM; Hedley DW
    Cancer Treat Rep; 1984; 68(7-8):1045-6. PubMed ID: 6744338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.
    Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB
    Oncology; 1977; 34(1):45-6. PubMed ID: 865760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
    Van Amburg AL; Presant CA; Burns D
    Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of carboplatin in advanced malignant melanoma.
    Evans LM; Casper ES; Rosenbluth R
    Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
    Nathanson L; Wittenberg BK
    Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
    Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN
    Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.